Stockscreener 앱 받기
1.21
0.83%
0.01
시장 영업 전:
1.25
0.04
+3.31%
전일 마감가:
$1.20
열려 있는:
$1.21
하루 거래량:
1.63M
Relative Volume:
0.70
시가총액:
$84.20M
수익:
$151.64M
순이익/손실:
$-37.23M
주가수익비율:
-2.2145
EPS:
-0.5464
순현금흐름:
$-13.58M
1주 성능:
-2.42%
1개월 성능:
-5.47%
6개월 성능:
-21.43%
1년 성능:
-65.33%
1일 변동 폭
$1.19
$1.275
1주일 범위
$1.19
$1.3888
52주 변동 폭
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.21 | 88.38M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics Names Sales Chief, Grants Equity Incentive - MyChesCo
STIM (NASDAQ) affiliate files to sell 42,164 vested shares via Fidelity - Stock Titan
STIM Technical Analysis | Trend, Signals & Chart Patterns | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics names Robert Greene as senior VP, sales - Medical Buyer
Neuronetics largest shareholder pushes for strategic review - Investing.com
Neuronetics Appoints Robert Greene as Senior Vice President Sales - The Globe and Mail
New Neuronetics sales chief gets 200,000-share stock grant - Stock Titan
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 - The Manila Times
New TMS data on teen and adult depression at CTMSS 2026 - Stock Titan
Neuronetics Stock Drops As Traders Watch New TMS Research Effort - Bez Kabli
Neuronetics, Inc. (STIM) Submits Form 8-K Reporting Shareholder Vote Results – Key Filing Details and Company Information - Minichart
What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout
Neuronetics (STIM) director Megan Rosengarten granted 30,000 RSUs, now holds 170,890 shares - Stock Titan
Director at Neuronetics (STIM) receives 30,000-share RSU grant - Stock Titan
Neuronetics (STIM) director awarded 30,000 RSUs vesting by 2027 - Stock Titan
Neuronetics (STIM) director Sheryl Conley awarded 30,000 RSUs in stock grant - Stock Titan
Neuronetics (STIM) director granted 36,250 RSUs, holdings rise to 625,017 shares - Stock Titan
Neuronetics (STIM) director Avinash Amin receives 30,000 RSU equity award - Stock Titan
Neuronetics (STIM) shareholders back directors, auditor and 2026 equity plan - Stock Titan
Neuronetics Inc stock (US63009R1005): Nasdaq shares steady as investors look beyond Q1 update - AD HOC NEWS
Neuronetics Inc stock (US63009R1005): shares little changed as investors weigh Q1 2026 update - AD HOC NEWS
Neuronetics (STIM) Holds at $1.22 as Stock Consolidates Near Key SupportActive ETF Flow - thelegaladvocate.com
PRISM MarketView Spotlights Seven Public Companies Advancing Mental Health Innovation During National Mental Health Awareness Month - StreetInsider
Large Neuronetics (STIM) holder discloses 15.17% stake and sole control - Stock Titan
STIMNeuronetics Inc Stock Price and Quote - Finviz
Neuronetics (STIM) Q1 2026 Earnings Transcript - AOL.com
Neuronetics, Inc. Signs $26,000/Month Consulting Agreement with Francis X. Brown III – 8-K Filing Details and Agreement Terms – Minichart - Minichart
Neuronetics Analyst Ratings and Price Targets | NASDAQ:STIM - Benzinga
Neuronetics Inc (STIM) Stock Price, Quote, News & History - Benzinga
Neuronetics updates consulting agreement for interim financial officer By Investing.com - Investing.com South Africa
Neuronetics updates consulting agreement for interim financial officer - Investing.com
Neuronetics (NASDAQ: STIM) sets new monthly pay for interim finance chief - Stock Titan
Neuronetics, Inc. Appoints Francis X. Brown III as Accounting Officer, Effective as of May 5, 2026 - marketscreener.com
Neuronetics (STIM) ex-CFO corrects insider sale to 8,569 tax-withheld shares - Stock Titan
STIM PE Ratio & Valuation, Is STIM Overvalued - Intellectia AI
STIM SEC FilingsNeuronetics 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buying: Jorey Chernett Acquires 100,000 Shares of Neuron - GuruFocus
Neuronetics 10% owner Chernett buys $117,000 in common stock By Investing.com - Investing.com South Africa
Neuronetics 10% owner Chernett buys $117,000 in common stock - Investing.com UK
Neuronetics (NASDAQ: STIM) large holder buys 100,000 shares - Stock Titan
Neuronetics(STIM) Stock Options Chain | Quotes & News - Moomoo
Neuronetics stock (US63009R1005): earnings move puts focus back on growth outlook - AD HOC NEWS
Neuronetics Revenue Rises as Clinic Business Expands - MyChesCo
Neuronetics partners with ANT Neuro on neuronavigation tech By Investing.com - Investing.com South Africa
Neuronetics and Ant Neuro announce strategic collaboration to integrate neuronavigation with Neurostar TMS treatment - marketscreener.com
Neuronetics partners with ANT Neuro on neuronavigation tech - Investing.com India
Neuronetics And Ant Neuro Announce Strategic Collaboration To Integrate Neuronavigation With Neurostar Tms Treatment - TradingView
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - The Manila Times
Neuronetics (STIM) interim PAO reports 19,968 Common Stock shares - Stock Titan
Insider Buying: Jorey Chernett Acquires 475,000 Shares of Neuron - GuruFocus
Neuronetics: Jorey Chernett buys $636,500 in shares By Investing.com - Investing.com India
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neuronetics Inc 주식 (STIM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chernett Jorey | 10% Owner |
May 19 '26 |
Buy |
1.17 |
100,000 |
117,000 |
10,553,988 |
| Chernett Jorey | 10% Owner |
May 12 '26 |
Buy |
1.34 |
475,000 |
636,500 |
10,453,988 |
| Chernett Jorey | 10% Owner |
Apr 20 '26 |
Buy |
1.58 |
100,000 |
158,000 |
9,878,988 |
| Chernett Jorey | 10% Owner |
Apr 21 '26 |
Buy |
1.51 |
100,000 |
151,000 |
9,978,988 |
| Chernett Jorey | 10% Owner |
Mar 30 '26 |
Buy |
1.25 |
385,442 |
481,802 |
9,778,988 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
| Chernett Jorey | 10% Owner |
Mar 25 '26 |
Buy |
1.40 |
125,000 |
175,000 |
8,868,276 |
| Chernett Jorey | 10% Owner |
Mar 26 '26 |
Buy |
1.44 |
25,000 |
36,000 |
8,893,276 |
| Pfanstiel Steven | EVP, CFO and Treasurer |
Mar 19 '26 |
Sale |
1.34 |
16,431 |
22,018 |
828,781 |
| Sullivan Keith J | Former Officer & Director |
Mar 19 '26 |
Sale |
1.34 |
46,289 |
62,027 |
1,590,924 |
2.43%
자본화:
|
볼륨(24시간):